-
1
-
-
0020544962
-
Sequential methotrexate and 5-fluorouracil treatment of squamous cell carcinoma of the head and neck
-
1 Ringborg U, Ewert G, Kinnman J, Lundqvist PG, Strander H: Sequential methotrexate and 5-fluorouracil treatment of squamous cell carcinoma of the head and neck. Cancer 1983; 52:971-973.
-
(1983)
Cancer
, vol.52
, pp. 971-973
-
-
Ringborg, U.1
Ewert, G.2
Kinnman, J.3
Lundqvist, P.G.4
Strander, H.5
-
2
-
-
0019431215
-
Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer
-
2 Gewirtz AM, Cadman E: Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer 1981; 47:2552-2555.
-
(1981)
Cancer
, vol.47
, pp. 2552-2555
-
-
Gewirtz, A.M.1
Cadman, E.2
-
3
-
-
0022641824
-
Sequential methotrexate-5-FU-leucovorin (MFL) in advanced colorectal cancer
-
3 Glimelius B, Ginman C, Graffman S, Pahlman L: Stahle E. Sequential methotrexate-5-FU-leucovorin (MFL) in advanced colorectal cancer. Eur J Cancer Clin Oncol 1986; 22:295-300.
-
(1986)
Eur J Cancer Clin Oncol
, vol.22
, pp. 295-300
-
-
Glimelius, B.1
Ginman, C.2
Graffman, S.3
Pahlman, L.4
Stahle, E.5
-
4
-
-
0020396015
-
Toxicity and response criteria of Eastern Cooperative Oncology Group
-
4 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-655.
-
(1982)
Am J Clin Oncol
, vol.5
, pp. 649-655
-
-
Oken, M.M.1
Creech, R.H.2
Tormey, D.C.3
Horton, J.4
Davis, T.E.5
McFadden, E.T.6
Carbone, P.P.7
-
5
-
-
84960575327
-
Accuracy of computed tomography in determining pancreatic cancer tumor size
-
5 Aoki K, Okada S, Moriyama N, Ishii H, Nose H, Yoshimori M, Tomoo K, Ozaki H, Wakao F, Takayasu K, Mukai K: Accuracy of computed tomography in determining pancreatic cancer tumor size. Jpn J Clin Oncol 1994; 24:85-87.
-
(1994)
Jpn J Clin Oncol
, vol.24
, pp. 85-87
-
-
Aoki, K.1
Okada, S.2
Moriyama, N.3
Ishii, H.4
Nose, H.5
Yoshimori, M.6
Tomoo, K.7
Ozaki, H.8
Wakao, F.9
Takayasu, K.10
Mukai, K.11
-
7
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
7 Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 63:457-481.
-
(1958)
J Am Stat Assoc
, vol.63
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
8
-
-
0023880296
-
Continuous 5-fluorouracil (5-FU) infusion in carcinoma of the pancreas: A phase II study
-
8 Hansen R, Quebbeman E, Ritch P, Chitambar C, Anderson T: Continuous 5-fluorouracil (5-FU) infusion in carcinoma of the pancreas: A phase II study. Am J Med Sci 1988; 295:91-93.
-
(1988)
Am J Med Sci
, vol.295
, pp. 91-93
-
-
Hansen, R.1
Quebbeman, E.2
Ritch, P.3
Chitambar, C.4
Anderson, T.5
-
9
-
-
0026010878
-
Phase II study of continuous venous infusion of 5-fluorouracil in advanced pancreatic cancer
-
9 Tajiri H,Yoshimori M, Okazaki N. Miyaji M: Phase II study of continuous venous infusion of 5-fluorouracil in advanced pancreatic cancer. Oncology 1991; 48:18-21.
-
(1991)
Oncology
, vol.48
, pp. 18-21
-
-
Tajiri, H.1
Yoshimori, M.2
Okazaki, N.3
Miyaji, M.4
-
10
-
-
0025841867
-
Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: Results of a phase II trial
-
10 DeCaprio JA, Mayer RJ, Gonin R, Arbuck SG: Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial. J Clin Oncol 1991; 9:2128-2133.
-
(1991)
J Clin Oncol
, vol.9
, pp. 2128-2133
-
-
DeCaprio, J.A.1
Mayer, R.J.2
Gonin, R.3
Arbuck, S.G.4
-
11
-
-
0025815267
-
Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma
-
11 Crown J, Casper ES, Botet J, Murray P, Kelsen DP: Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol 1991; 9:1682-1686.
-
(1991)
J Clin Oncol
, vol.9
, pp. 1682-1686
-
-
Crown, J.1
Casper, E.S.2
Botet, J.3
Murray, P.4
Kelsen, D.P.5
-
12
-
-
0026757016
-
Phase II evaluation of fluorouracil and recombinant α-2a-interferon in previously untreated patients with pancreatic adenocarcinoma
-
12 Pazdur R, Ajani JJ, Abbruzzese JL, Belt RJ, Dakhil SR, Dubovsky D, Graham S, Pilat S, Winn R, Levin B: Phase II evaluation of fluorouracil and recombinant α-2a-interferon in previously untreated patients with pancreatic adenocarcinoma. Cancer 1992; 70:2073-2076.
-
(1992)
Cancer
, vol.70
, pp. 2073-2076
-
-
Pazdur, R.1
Ajani, J.J.2
Abbruzzese, J.L.3
Belt, R.J.4
Dakhil, S.R.5
Dubovsky, D.6
Graham, S.7
Pilat, S.8
Winn, R.9
Levin, B.10
-
13
-
-
0026738325
-
A phase II trial of 5-fluorouracil, leuovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas
-
13 Scheithauer W, Pfeffel F, Kornek G, Marczell A, Wiltschke C, Funovics J: A phase II trial of 5-fluorouracil, leuovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas. Cancer 1992; 70:1864-1866.
-
(1992)
Cancer
, vol.70
, pp. 1864-1866
-
-
Scheithauer, W.1
Pfeffel, F.2
Kornek, G.3
Marczell, A.4
Wiltschke, C.5
Funovics, J.6
-
14
-
-
0025941816
-
A phase I, II study of high dose 5-fluorouracil and high-dose leucovorin with low dose phosphonacelyl-I-aspartic acid in patients with advanced malignancies
-
14 Ardalan B, Sridhar KS, Benedetto P, Richman S, Waldman S, Morrell L, Feun L, Savaraj N, Fodor M, Livingstone A: A phase I, II study of high dose 5-fluorouracil and high-dose leucovorin with low dose phosphonacelyl-I-aspartic acid in patients with advanced malignancies. Cancer 1991; 68: 1242-1246.
-
(1991)
Cancer
, vol.68
, pp. 1242-1246
-
-
Ardalan, B.1
Sridhar, K.S.2
Benedetto, P.3
Richman, S.4
Waldman, S.5
Morrell, L.6
Feun, L.7
Savaraj, N.8
Fodor, M.9
Livingstone, A.10
-
15
-
-
0018700143
-
Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: Explanation for drug synergism
-
15 Cadman E, Heimer R, Davis L: Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: Explanation for drug synergism. Science 1979; 205:1135-1137.
-
(1979)
Science
, vol.205
, pp. 1135-1137
-
-
Cadman, E.1
Heimer, R.2
Davis, L.3
-
16
-
-
0019804957
-
The role of methotrexate and dihydrofolate polyglutamates in enhancement of fluorouracil action by methotrexate
-
16 Fernandes DJ, Moroson BA, Bertino JR: The role of methotrexate and dihydrofolate polyglutamates in enhancement of fluorouracil action by methotrexate. Cancer Treat Rep 1981; 65:29-35.
-
(1981)
Cancer Treat Rep
, vol.65
, pp. 29-35
-
-
Fernandes, D.J.1
Moroson, B.A.2
Bertino, J.R.3
-
17
-
-
0030780051
-
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma
-
17 Harstrick A, Kohne CH, Hiddemann W, Preusser P, Strumberg D, Berns T, Seeber S, Wilke H, Schmoll HJ: Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma. Ann Oncol 1997:8:917-918.
-
(1997)
Ann Oncol
, vol.8
, pp. 917-918
-
-
Harstrick, A.1
Kohne, C.H.2
Hiddemann, W.3
Preusser, P.4
Strumberg, D.5
Berns, T.6
Seeber, S.7
Wilke, H.8
Schmoll, H.J.9
-
18
-
-
8944261362
-
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer
-
18 Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM, Von Hoff DD: A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol 1996; 7:347-353.
-
(1996)
Ann Oncol
, vol.7
, pp. 347-353
-
-
Rothenberg, M.L.1
Moore, M.J.2
Cripps, M.C.3
Andersen, J.S.4
Portenoy, R.K.5
Burris H.A. III6
Green, M.R.7
Tarassoff, P.G.8
Brown, T.D.9
Casper, E.S.10
Storniolo, A.M.11
Von Hoff, D.D.12
-
19
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: A randomized trial
-
19 Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelsen R, Dorr FA, Stephens CD, Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: A randomized trial. J Clin Oncol 1997; 15:2403-2413.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2403-2413
-
-
Burris H.A. III1
Moore, M.J.2
Andersen, J.3
Green, M.R.4
Rothenberg, M.L.5
Modiano, M.R.6
Cripps, M.C.7
Portenoy, R.K.8
Storniolo, A.M.9
Tarassoff, P.10
Nelsen, R.11
Dorr, F.A.12
Stephens, C.D.13
Von Hoff, D.D.14
|